United States

Astellas Pharma Inc (4503.T)

4503.T on Tokyo Stock Exchange

10:29pm EDT
Change (% chg)

¥2 (+0.08%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Yoshihiko Hatanaka

61 2018 Chairman of the Board, Chairman of the Board of Directors, Representative Director

Kenji Yasukawa

57 2018 President, Chief Executive Officer, Representative Director

Chikashi Takeda

2017 Chief Financial Officer, Executive Officer

Bernhardt Zeiher

2018 President - Development, Chief Medical Officer

Fumiaki Sakurai

2017 Chief Administrative Officer, Chief Ethics & Compliance Officer, Executive Officer